Allscripts (MDRX) Misses Q4 EPS by 1c, Offers Guidnce
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/30/2026
- Crude Inventory Fell 7.2 Million Barrels Last Week - EIA
- SoFi Technologies (SOFI) Tops Q2 EPS by 1c ; Offers Guidance
- Wall Street closes down sharply after Fed holds rates unchanged
- How will the S&P 500 react to today’s FOMC? JPM lays out the playbook
- Grant Thornton Advisors to buy CBIZ in $5 billion deal, expand US accounting reach
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
Jefferies Reiterates Buy on Allscripts (MDRX) Following 4Q
February 17, 2017 8:26 AM ESTJefferies reiterated a Buy rating and $16.50 price target on Allscripts (NASDAQ: MDRX) following 4Q earnings report. MDRX reported EPS of $0.14, which compares to $0.15 for consensus. Downside was driven by higher SG&A, partially offset by better revenue, a higher gross margin and... More
Allscripts (MDRX) PT Raised to $13 at Cantor Fitzgerald Following In-Line 4Q Results
February 17, 2017 7:22 AM ESTCantor Fitzgerald analyst Steven Halper reiterates Neutral rating and raises price target on Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) to $13 (from $12), suggesting shares remain fairly valued, as the company reported 2016 fourth quarter results in-line with estimates, while 2017 guidance was also in-line with... More
